Updated on 25 May 2012
Plans involving foreign direct investment are compelling Indian companies to build a team of internationally qualified manpower. Ranbaxy is planning to set up a manufacturing facility in Malaysia and is also eyeing Australia with the launch of Atorvastatin. The company is also looking to invest in Africa, a region where the firm has witnessed substantial growth. It is setting up a manufacturing facility in Nigeria to supplement manufacturing capability and is also looking to explore significant opportunities in Morocco.
The company, with its ambition in different geographies, is concentrating on a multicultural human resource skills. It initiated a talent exchange program with Daiichi Sankyo to create cultural synergies and skill enhancement. As a part of this initiative, 13 expatriates from Daiichi Sankyo also joined the Ranbaxy fraternity in 2011.
"Development of human capital is one of the most critical components of Ranbaxy's growth. We re-structured our management training program to develop a highly motivated, innovative, alert, forward looking and ethically committed team to play a key role in ensuring the company's future progress. Developing global leaders for a new global market place is an area of importance for Ranbaxy," says Mr Arun Sawhney, CEO, Ranbaxy.
Ranbaxy has over 14,000 employees worldwide, of which 1,300 are in R&D and quality, 3,000 are in manufacturing and 9,000 employees are in the global pharmaceutical business.
Apart from establishing their footprint outside the regional market, Asian companies have proven to be potential partners for world's leading companies. This has helped them polish the skills of human resources, thus elevating them to international standards. India-based Dr Reddy's Laboratories formed strategic partnership with GlaxoSmithKline (GSK) and is developing and marketing key products for GSK across emerging markets outside India. For supporting its international exposure, Dr Reddy's has continued to strengthen and build a strong work force. Dr Reddy's global employee strength surpassed 14,900 in 2010-11, of which over 2,400 were based at international locations.